<DOC>
	<DOCNO>NCT02101541</DOCNO>
	<brief_summary>The FIRM Study Oslo two sequential within-patient trial investigate efficacy focal impulse rotor modulation ( FIRM ) stand-alone procedure treatment paroxysmal persistent atrial fibrillation , evaluate continuous pre- post-procedural heart rhythm monitoring .</brief_summary>
	<brief_title>FIRM Stand-alone Procedure Treatment Atrial Fibrillation</brief_title>
	<detailed_description>After pilot/implementation study consist 10 patient paroxysmal atrial fibrillation ( AF ) ; 20 patient paroxysmal AF include within-patient trial . This study follow similar comparison 20 patient persistent longstanding persistent AF . The AF driving source visualize novel sequential bi-atrial panoramic contact mapping technique . Unipolar signal record 64-polar basket catheter ( FIRMap® , Topera . Inc. ) , process activation pattern visualize ( RhythmView® 3D Electrophysiologic Mapping System , Topera , Inc. ) . Focal impulse rotor modulation ( FIRM ) perform standard irrigated radio frequency catheter ablation rotor focal impulse elimination confirm repeat FIRM mapping . Treatment efficacy assess continuous heart rhythm monitor ( Reveal XT® , Medtronic , Minneapolis , USA ) implant 3 month prior ablation , freedom AF define AF burden &lt; 1 % follow-up 12 , 24 30 month .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Paroxysmal atrial fibrillation despite least one Class I Class III antiarrhythmic drug and/or previous conventional ablation ( pulmonary vein isolation ) . At least one episode paroxysmal atrial fibrillation document rhythm strip , ECG implant monitor last 6 month prior ablation . Significant structural heart disease ( include symptomatic coronary heart disease ; prosthetic mitral tricuspid valve ; congenital heart disease abnormality correction prohibit increase risk ablation ) . Intracardiac thrombus , tumor dense contrast TEE . Contraindication anticoagulant therapy ( heparin , warfarin , dabigatran rivaroxaban ) . Anaphylactic allergy contrast medium . Poor general health result disease . Inability refusal provide write informed consent study .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Arrhythmias , Cardiac</keyword>
	<keyword>Heart disease</keyword>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Pathological process</keyword>
</DOC>